AAPL321.42-4.47 (-1.37%) ▼|ABBV257.38+4.08 (+1.61%) ▲|ABT100.77+0.20 (+0.20%) ▲|ACN138.23-1.86 (-1.33%) ▼|ADBE213.31-5.05 (-2.31%) ▼|AMAT565.52+11.60 (+2.09%) ▲|AMD542.30-10.03 (-1.82%) ▼|AMGN367.21+1.16 (+0.32%) ▲|AMT166.92+0.86 (+0.52%) ▲|AMZN234.30-10.55 (-4.31%) ▼|AVGO390.31-6.50 (-1.64%) ▼|AXP341.72-7.02 (-2.01%) ▼|BA208.58-0.07 (-0.03%) ▼|BAC61.04-0.58 (-0.94%) ▼|BKNG172.85-5.01 (-2.82%) ▼|BLK1,042.19-14.45 (-1.37%) ▼|BMY61.65+0.89 (+1.46%) ▲|BNY159.63-0.76 (-0.47%) ▼|BRK-B489.34-0.05 (-0.01%) ▼|C131.86-0.39 (-0.29%) ▼|CAT906.23+16.92 (+1.90%) ▲|CL89.70-1.93 (-2.11%) ▼|CMCSA22.68-0.85 (-3.59%) ▼|COF198.29-3.08 (-1.53%) ▼|COP121.72+2.93 (+2.47%) ▲|COST918.47-8.84 (-0.95%) ▼|CRM158.40-4.60 (-2.82%) ▼|CSCO113.14+0.93 (+0.83%) ▲|CVS106.38-1.04 (-0.97%) ▼|CVX196.36+3.38 (+1.75%) ▲|DE613.55+6.22 (+1.02%) ▲|DHR189.63+10.49 (+5.86%) ▲|DIS93.02-2.85 (-2.97%) ▼|DUK128.78+0.83 (+0.65%) ▲|EMR143.68+4.05 (+2.90%) ▲|FDX315.87-5.16 (-1.61%) ▼|GD384.29+11.13 (+2.98%) ▲|GE348.91+7.72 (+2.26%) ▲|GEV1,018.69+33.66 (+3.42%) ▲|GILD130.05-0.30 (-0.23%) ▼|GM79.59-2.54 (-3.09%) ▼|GOOG320.49-21.43 (-6.27%) ▼|GOOGL320.67-21.42 (-6.26%) ▼|GS1,073.70-24.50 (-2.23%) ▼|HD325.57-5.88 (-1.77%) ▼|HON247.34+14.35 (+6.16%) ▲|IBM207.14+1.37 (+0.67%) ▲|INTC101.41-1.21 (-1.18%) ▼|INTU281.76-2.71 (-0.95%) ▼|ISRG332.92-7.78 (-2.28%) ▼|JNJ258.58+2.95 (+1.15%) ▲|JPM348.05-0.16 (-0.05%) ▼|KO81.04-1.16 (-1.41%) ▼|LIN506.54-2.13 (-0.42%) ▼|LLY1,182.93+19.92 (+1.71%) ▲|LMT574.44+60.08 (+11.68%) ▲|LOW201.27-3.08 (-1.51%) ▼|LRCX320.30+1.01 (+0.31%) ▲|MA527.11-4.87 (-0.92%) ▼|MCD262.86-0.71 (-0.27%) ▼|MDLZ59.85-1.01 (-1.66%) ▼|MDT82.08+0.19 (+0.23%) ▲|META603.69-23.48 (-3.74%) ▼|MMM170.22-0.55 (-0.32%) ▼|MO71.78-0.40 (-0.55%) ▼|MRK130.77+3.30 (+2.58%) ▲|MS214.63-3.87 (-1.77%) ▼|MSFT381.05-9.29 (-2.38%) ▼|MU990.93+31.45 (+3.28%) ▲|NEE89.92+0.51 (+0.57%) ▲|NFLX68.69+0.16 (+0.23%) ▲|NKE40.99-1.22 (-2.89%) ▼|NOW94.70-0.76 (-0.80%) ▼|NVDA209.29-2.77 (-1.31%) ▼|ORCL121.01-4.83 (-3.84%) ▼|PEP134.72-0.94 (-0.69%) ▼|PFE25.00+0.18 (+0.71%) ▲|PG146.33-2.80 (-1.88%) ▼|PLTR121.94-2.63 (-2.11%) ▼|PM191.73-2.57 (-1.32%) ▼|QCOM169.45-6.18 (-3.52%) ▼|RTX209.65+14.77 (+7.58%) ▲|SBUX102.55-1.44 (-1.38%) ▼|SCHW102.30+1.50 (+1.49%) ▲|SO95.91+0.11 (+0.11%) ▲|SPG227.16+0.94 (+0.42%) ▲|T22.77-0.27 (-1.17%) ▼|TMO573.78+47.32 (+8.99%) ▲|TMUS177.76-13.18 (-6.90%) ▼|TSLA325.45-48.56 (-12.98%) ▼|TXN283.14-11.05 (-3.76%) ▼|UBER69.67-0.67 (-0.95%) ▼|UNH420.81-10.50 (-2.43%) ▼|UNP309.77+17.21 (+5.88%) ▲|UPS115.45-0.40 (-0.34%) ▼|USB63.15-1.32 (-2.05%) ▼|V349.45-3.97 (-1.12%) ▼|VZ44.29+0.00 (+0.00%) ▲|WFC85.78-0.64 (-0.74%) ▼|WMT107.08-2.25 (-2.06%) ▼|XOM157.81+3.36 (+2.18%) ▲|AAPL321.42-4.47 (-1.37%) ▼|ABBV257.38+4.08 (+1.61%) ▲|ABT100.77+0.20 (+0.20%) ▲|ACN138.23-1.86 (-1.33%) ▼|ADBE213.31-5.05 (-2.31%) ▼|AMAT565.52+11.60 (+2.09%) ▲|AMD542.30-10.03 (-1.82%) ▼|AMGN367.21+1.16 (+0.32%) ▲|AMT166.92+0.86 (+0.52%) ▲|AMZN234.30-10.55 (-4.31%) ▼|AVGO390.31-6.50 (-1.64%) ▼|AXP341.72-7.02 (-2.01%) ▼|BA208.58-0.07 (-0.03%) ▼|BAC61.04-0.58 (-0.94%) ▼|BKNG172.85-5.01 (-2.82%) ▼|BLK1,042.19-14.45 (-1.37%) ▼|BMY61.65+0.89 (+1.46%) ▲|BNY159.63-0.76 (-0.47%) ▼|BRK-B489.34-0.05 (-0.01%) ▼|C131.86-0.39 (-0.29%) ▼|CAT906.23+16.92 (+1.90%) ▲|CL89.70-1.93 (-2.11%) ▼|CMCSA22.68-0.85 (-3.59%) ▼|COF198.29-3.08 (-1.53%) ▼|COP121.72+2.93 (+2.47%) ▲|COST918.47-8.84 (-0.95%) ▼|CRM158.40-4.60 (-2.82%) ▼|CSCO113.14+0.93 (+0.83%) ▲|CVS106.38-1.04 (-0.97%) ▼|CVX196.36+3.38 (+1.75%) ▲|DE613.55+6.22 (+1.02%) ▲|DHR189.63+10.49 (+5.86%) ▲|DIS93.02-2.85 (-2.97%) ▼|DUK128.78+0.83 (+0.65%) ▲|EMR143.68+4.05 (+2.90%) ▲|FDX315.87-5.16 (-1.61%) ▼|GD384.29+11.13 (+2.98%) ▲|GE348.91+7.72 (+2.26%) ▲|GEV1,018.69+33.66 (+3.42%) ▲|GILD130.05-0.30 (-0.23%) ▼|GM79.59-2.54 (-3.09%) ▼|GOOG320.49-21.43 (-6.27%) ▼|GOOGL320.67-21.42 (-6.26%) ▼|GS1,073.70-24.50 (-2.23%) ▼|HD325.57-5.88 (-1.77%) ▼|HON247.34+14.35 (+6.16%) ▲|IBM207.14+1.37 (+0.67%) ▲|INTC101.41-1.21 (-1.18%) ▼|INTU281.76-2.71 (-0.95%) ▼|ISRG332.92-7.78 (-2.28%) ▼|JNJ258.58+2.95 (+1.15%) ▲|JPM348.05-0.16 (-0.05%) ▼|KO81.04-1.16 (-1.41%) ▼|LIN506.54-2.13 (-0.42%) ▼|LLY1,182.93+19.92 (+1.71%) ▲|LMT574.44+60.08 (+11.68%) ▲|LOW201.27-3.08 (-1.51%) ▼|LRCX320.30+1.01 (+0.31%) ▲|MA527.11-4.87 (-0.92%) ▼|MCD262.86-0.71 (-0.27%) ▼|MDLZ59.85-1.01 (-1.66%) ▼|MDT82.08+0.19 (+0.23%) ▲|META603.69-23.48 (-3.74%) ▼|MMM170.22-0.55 (-0.32%) ▼|MO71.78-0.40 (-0.55%) ▼|MRK130.77+3.30 (+2.58%) ▲|MS214.63-3.87 (-1.77%) ▼|MSFT381.05-9.29 (-2.38%) ▼|MU990.93+31.45 (+3.28%) ▲|NEE89.92+0.51 (+0.57%) ▲|NFLX68.69+0.16 (+0.23%) ▲|NKE40.99-1.22 (-2.89%) ▼|NOW94.70-0.76 (-0.80%) ▼|NVDA209.29-2.77 (-1.31%) ▼|ORCL121.01-4.83 (-3.84%) ▼|PEP134.72-0.94 (-0.69%) ▼|PFE25.00+0.18 (+0.71%) ▲|PG146.33-2.80 (-1.88%) ▼|PLTR121.94-2.63 (-2.11%) ▼|PM191.73-2.57 (-1.32%) ▼|QCOM169.45-6.18 (-3.52%) ▼|RTX209.65+14.77 (+7.58%) ▲|SBUX102.55-1.44 (-1.38%) ▼|SCHW102.30+1.50 (+1.49%) ▲|SO95.91+0.11 (+0.11%) ▲|SPG227.16+0.94 (+0.42%) ▲|T22.77-0.27 (-1.17%) ▼|TMO573.78+47.32 (+8.99%) ▲|TMUS177.76-13.18 (-6.90%) ▼|TSLA325.45-48.56 (-12.98%) ▼|TXN283.14-11.05 (-3.76%) ▼|UBER69.67-0.67 (-0.95%) ▼|UNH420.81-10.50 (-2.43%) ▼|UNP309.77+17.21 (+5.88%) ▲|UPS115.45-0.40 (-0.34%) ▼|USB63.15-1.32 (-2.05%) ▼|V349.45-3.97 (-1.12%) ▼|VZ44.29+0.00 (+0.00%) ▲|WFC85.78-0.64 (-0.74%) ▼|WMT107.08-2.25 (-2.06%) ▼|XOM157.81+3.36 (+2.18%) ▲|
23.7 C
New York
Thursday, July 23, 2026

Tag: FR0000120578

newssourceFORcompanyinformationcontent1releasesmarket

Press Release: EAACI: Dupixent demonstrated superiority over Xolair (omalizumab) in chronic rhinosinusitis with nasal polyps in patients with coexisting asthma in first-ever presented phase...

EAACI: Dupixent demonstrated superiority over Xolair (omalizumab) in chronic rhinosinusitis with nasal polyps in patients with coexisting asthma in first-ever presented phase 4 head-to-head respiratory study

Communiqué : Dupixent a démontré sa supériorité par rapport au Xolair dans la rhinosinusite chronique avec polypes nasaux chez des patients atteints d’asthme coexistant...

EAACI : Le Dupixent a démontré sa supériorité par rapport au Xolair (omalizumab) dans la rhinosinusite chronique avec polypes nasaux chez des patients atteints d’asthme coexistant dans la toute première étude respiratoire de phase 4 en comparaison directe jamais présentée

Sanofi: Information concerning the total number of voting rights and shares – May 2025

Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of the Code de commerce (the French Commercial Code) and article 223-16 of the Règlement général de l’Autorité des Marchés Financiers (Regulation of the French stock market authority)

Sanofi: Informations relatives au nombre de droits de vote et d’actions – Mai 2025

Informations relatives au nombre total de droits de vote et d’actions prévues par l’article L. 233-8 II du Code de commerce et l’article 223-16 du Règlement général de l’Autorité des Marchés Financiers

Press Release: Sanofi accelerates global shipping of Beyfortus to prepare healthcare providers months ahead of 2025-2026 RSV season

Sanofi accelerates global shipping of Beyfortus to prepare healthcare providers months ahead of 2025-2026 RSV season

Communiqué de presse : Sanofi accélère la livraison mondiale de Beyfortus pour préparer les professionnels de santé plusieurs mois avant la saison 2025-2026 de...

Sanofi accélère la livraison mondiale de Beyfortus pour préparer les professionnels de santé plusieurs mois avant la saison 2025-2026 de VRS

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsFR0000120578

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers